P8 - Research technologies break-out (Novo Nordisk Capital Markets Day 2022) (27:53)
Research technologies, break-out session.
Marcus Schindler, CSO and EVP of Research & Early Developement Karin Conde-Knape, SVP Global drug discovery Lars Fogh Iversen, SVP Global research technologies
Research technologies, break-out session.
Marcus Schindler, CSO and EVP of Research & Early Developement Karin Conde-Knape, SVP Global drug discovery Lars Fogh Iversen, SVP Global research technologies
Hide again